NovaSeq 6000 SP Reagent Kit v1.5 (200 cycles)
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring NovaSeq 6000 SP Reagent Kit v1.5 (200 cycles), a flow cell and reagent consumable set designed to support a single SP flow cell 200-cycle NovaSeq run. The solicitation is estimated to release on February 1, 2027, with award anticipated on April 1, 2027. This is classified as a new requirement under NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences, except Nanotechnology and Biotechnology) with no set-aside applied.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA Center for Biologics Evaluation and Research Acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
NovaSeq 6000 SP Reagent Kit v1.5 (200 cycles)This reagent kit provides the flow cell and reagent consumables to support a single SP flow cell 200 cycles NovaSeq run.Priority 1
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast